SEC Filings | PureTech Health

Filing date	Form	Description	Filing Group	View
2024-03-19	SC TO-C	Written public communication relating to an issuer or third party tender offer	Mergers & Acquisitions	0001193125-24-070822.pdf 0001193125-24-070822.rtf 0001193125-24-070822.xls View HTML
2023-05-03	4	Statement of changes in beneficial ownership of securities	3,4,5	0000899243-23-012087.pdf 0000899243-23-012087.rtf 0000899243-23-012087.xls View HTML
2023-05-31	4	Statement of changes in beneficial ownership of securities	3,4,5	0000899243-23-014169.pdf 0000899243-23-014169.rtf 0000899243-23-014169.xls View HTML
2023-06-14	4	Statement of changes in beneficial ownership of securities	3,4,5	0000899243-23-015533.pdf 0000899243-23-015533.rtf 0000899243-23-015533.xls View HTML
2023-09-21	4	Statement of changes in beneficial ownership of securities	3,4,5	0000950170-23-049198.pdf 0000950170-23-049198.rtf 0000950170-23-049198.xls View HTML
2021-01-29	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001193125-21-021507.pdf 0001193125-21-021507.rtf 0001193125-21-021507.xls View HTML
2021-02-05	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001193125-21-029720.pdf 0001193125-21-029720.rtf 0001193125-21-029720.xls View HTML
2021-02-10	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001193125-21-035138.pdf 0001193125-21-035138.rtf 0001193125-21-035138.xls View HTML
2021-03-15	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001193125-21-080408.pdf 0001193125-21-080408.rtf 0001193125-21-080408.xls View HTML
2021-03-18	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001193125-21-084745.pdf 0001193125-21-084745.rtf 0001193125-21-084745.xls View HTML

Data provided by Kaleidoscope.